Skip Navigation

Pipeline

Oncology

All Arvinas programs are wholly owned

Program
Discovery
Lead Optimization
IND Enabling
Phase 1
Phase 2/3

Prostate Cancer

Phase 1

Next Generation Degrader Androgen Receptor

IND Enabling

AR Variant Degrader AR-V7

Discovery

Breast Cancer

Phase 1

Additional Oncology Programs

Multiple Indications Undisclosed Targets

Lead Optimization

Neuroscience

All Arvinas programs are wholly owned

Program
Discovery
Lead Optimization
IND Enabling
Phase 1
Phase 2/3

FTLD-Tau, PSP, Alzheimer's

Tau

Lead Optimization

MSA, Parkinson's

Discovery

Additional Neurology Programs